ArticleMolecular cancer therapeutics2017

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Joo Ern Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.